Pliva Hrvatska Overview
- Founded
-
1921
- Status
-
Acquired/Merged
- Latest Deal Type
-
PIPE
- Financing Rounds
-
3
Pliva Hrvatska General Information
Description
Manufacturer and provider of pharmaceutical products. The company's pharmaceutical products include development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients, enabling clients to get quality and cost effective pharmaceutical products.
Contact Information
Formerly Known As
Kastel d.d.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
- Prilaz baruna Filipovića 25
- Zagreb, 10000
- Croatia
+385 01 0000 000
Pliva Hrvatska Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pliva Hrvatska Patents
Pliva Hrvatska Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3999514-A1 | Crystalline lorlatinib : fumaric acid and solid state form thereof | Pending | 18-Jul-2019 | 0000000000 | |
| EP-3830184-A1 | Solid state forms of sugammadex sodium | Pending | 02-Aug-2018 | 000000000 | |
| US-20210292479-A1 | Solid state forms of sugammadex sodium | Pending | 02-Aug-2018 | 000000000 | |
| EP-3784675-A1 | Solid state forms of lorlatinib and their preparation | Pending | 23-Apr-2018 | 0000000000 | |
| US-20210163498-A1 | Solid state forms of lorlatinib and their preparation | Pending | 23-Apr-2018 | C07D498/18 |
Pliva Hrvatska Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Željko Čović | Chief Executive Officer | ||
| Mihael Furjan | President | ||
| Nikolina Čehulić | Chief Financial Officer | ||
| Matko Bolanča | Chief Executive Officer |